Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Strides Pharma gets USFDA nod for generic version of Edecrin Tablets

Ruchika Sharma20 Oct 2020 11:57 AM IST

The product will be manufactured at the company's flagship facility at Bengaluru and will be marketed by Strides Pharma Inc. in the US market.

BDR Pharma unveils idiopathic pulmonary fibrosis drug Nintedanib in India

Ruchika Sharma20 Oct 2020 11:06 AM IST

IPF is lung disorder where there is scarring of the lungs due to an unknown cause, BDR Pharmaceuticals said in a statement.

COVID-19: Indonesia to provide vaccines to 9.1 million people at 1st phase

Ruchika Sharma20 Oct 2020 10:00 AM IST

Jakarta: Indonesia will at the first phase provide the Covid-19 vaccine to 9.1 million people between November and December 2020, the Health...

Israel to begin Covid vaccine Brilife trials by October end

Ruchika Sharma20 Oct 2020 9:15 AM IST

Israel had claimed in August that it already has the vaccine against the coronavirus "in hand" but it has to go through regulatory processes that...

Zydus Cadila gets tentative USFDA approval for Tofacitinib ER Tablets

Ruchika Sharma19 Oct 2020 2:34 PM IST

Ahmedabad: Drugmaker, Zydus Cadila, today announced that the company has received tentative approval from the United States Food & Drug...

Glenmark gets USFDA nod to generic version of Rapamune

Ruchika Sharma19 Oct 2020 2:00 PM IST

Mumbai: Drugmaker, Glenmark Pharmaceuticals Inc., USA today announced that the company has received final approval by the United States Food...

Dr Reddys, RDIF get DCGI nod for Russian Covid vaccine trial

Ruchika Sharma19 Oct 2020 1:30 PM IST

Hyderabad: Dr. Reddy's Laboratories Ltd. and Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, has recently announced that they...

Bharat Biotech, Serum Institute to begin trials of intranasal COVID vaccines: Dr Harsh Vardhan

Ruchika Sharma19 Oct 2020 1:00 PM IST

New Delhi: Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal Covid-19 vaccines in the coming...

Earliest US filing for COVID vaccine would be late November: Pfizer

Ruchika Sharma19 Oct 2020 11:00 AM IST

New York: Pfizer Inc said on Friday it could file in late November for US authorization of the COVID-19 vaccine it is developing, suggesting that a...

Parliamentary Panel Slams CDSCO for Slow Drug Approvals, Calls for Conditional Licensing in 45 Days

CDSCO Flags 22 Drug Samples As Not Of Standard Quality

Ruchika Sharma18 Oct 2020 11:00 AM IST

New Delhi: The apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 10 drug samples as 'Not of Standard Quality'...

USFDA okays Zydus Cadila Ursodiol Capsules, while tentative nod to Linagliptin, Metformin Hydrochloride Tablets

Ruchika Sharma18 Oct 2020 10:15 AM IST

Ahmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received final approval from the US Food & Drug...

Pfizer-BioNTech COVID vaccine trial remains on track, says CEO

Ruchika Sharma18 Oct 2020 10:00 AM IST

New Delhi: Side effects that have emerged in a large late-stage trial of a Covid-19 vaccine candidate from Pfizer Inc. and BioNTech SE are in line...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok